Skip to Content

ABG 30 (Morphine sulphate extended-release 30 mg)

Pill imprint ABG 30 has been identified as Morphine sulphate extended-release 30 mg.

Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Morphine sulphate extended-release 30 mg ABG 30
Morphine sulphate extended-release 30 mg ABG 30
Morphine sulphate extended-release 30 mg ABG 30
Morphine sulphate extended-release
Imprint:
ABG 30
Strength:
30 mg
Color:
Purple
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3512

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide